FDCA
Search documents
Bio-based 2026展览③ | 中科国生:PEF新型全生物基功能纤维、PEF高阻隔包装等产品即将亮相
合成生物学与绿色生物制造· 2026-02-24 03:14
关键词| 生物基大会 | 中科国生 作为生物基行业风向标, Bio-based 2026 第11届生物基大会暨展览 火热报名中,展会 将于5月20-22日在上海举办,以 " 11 场主题论坛 + 7大 同期活动 + 1000 个新品展示 + #DT新叶奖 评选&颁奖 " 为载体,全链条助力我国"十五五" 生物基产业创新发展与上下游交流合作,促进国际生物 基技术和产业交流。 诚邀行业专家、企业和机构代表报名 演讲、参会参展 ;终端品牌商参会 对接新品、分享交流 。 呋喃生物基材料全产业链先行者 —— 中科国生(杭州)科技有限公司 将出席Bio-based 2026第11届生物基大会,并参加展览, 展位号C12 ,欢迎 行业同仁参观交流,不见不散! 1 企业介绍 中科国生(杭州)科技有限公司 是全球生物基材料制造领域的先行者,专注于呋喃类化学品的创新开发与产业化。凭借自研的连续化工艺和短流程生 产方案,公司实现了5-羟甲基糠醛(HMF)、呋喃二甲酸(FDCA)等关键化合物和单体的规模化生产,并成功在包装、纤维、芳纶等行业实现新原 料的产业化落地。中科国生将不断以"用生物质改变生活"的价值愿景,为全球客户提供高性能 ...
生物基材料企业「利夫生物」PEF通过国家食品接触材料审批!
synbio新材料· 2026-02-05 07:41
声明: 因水平有限,错误不可避免,或有些信息非最及时,欢迎留言指出。本文由仅作新材料相关领域介绍,本文不构成任何投资建议!转载请注明来源! 近日,国家卫生健康委国家食品安全风险评估中心(China National Center for Food Safety Risk Assessment) 通知,依据《中华人民共和国食品安全法》 相关规定,评审机构 以利夫生物相关产品为基本材料 审查了 PEF(聚2,5﹣呋喃二甲酸乙二醇酯) 作为食品相关产品新品种的安全性评估,并审查通过。 这预示着,利夫生物相关产品将被正式纳入《GB 4806.7-2023食品安全国家标准食品接触用塑料材料及制品》清单, 获准在中华人民共和国境内用于食品 接触用途。 食品接触材料的合规性,建立在材料本身的安全性与稳定性之上。通过十余年的持续研发与工程化积累,利夫生物率先将产业化 FDCA 的纯度提升至 99.99%,并围绕可能影响食品接触安全的微量杂质建立了严格的筛查与控制体系。在此基础上开发的 PEF 产品,经专家委员会评估其单体迁移测试及 NIAS(非有意添加物质)筛查等关键指标,均表现出高度稳定性, 相关数据显著优于国际同类企业 ...
DT新叶奖第①批公示: 万华化学/利夫生物/骐业科技/聚维元创/华呋新材/浩森生物等亮相(持续更新)
合成生物学与绿色生物制造· 2026-01-16 04:14
Core Viewpoint - The "2026 DT New Leaf Award" is a global and comprehensive award focused on innovation in the bio-based sector, aimed at discovering, showcasing, and recognizing outstanding products and companies in the bio-based industry [2]. Group 1: Award Overview - The award symbolizes vitality and sustainable innovation, with the goal of uncovering pioneering forces in the bio-based industry that utilize renewable biomass and green technologies to drive low-carbon development [2]. - Over 30 representative companies from the bio-based industry are participating in the "2026 DT New Leaf Award" evaluation, with the first batch of participating companies announced [2]. Group 2: Participating Companies and Products - Wanhua Chemical Group Co., Ltd. is recognized as a leading global chemical new materials enterprise, participating with its low-carbon PCDL product, which is a versatile polyol used for high-end polyurethane materials [3]. - Leaf Bio, a global leader in bio-based aromatic materials, focuses on the development and production of furan-based materials, with core products FDCA and PEF being recognized as potential bio-based platform compounds [4]. - Henan Qiye Technology Development Co., Ltd. is the world's first company to produce non-food cellulose crystalline glucose in bulk, showcasing its innovative production techniques [5]. - Suzhou Polywin Biotechnology Co., Ltd. specializes in straw-based bio-manufacturing, presenting products such as bio-based 1,4-butanediamine and fully bio-based packaging materials [8]. - Ningbo Huafu New Materials Technology Co., Ltd. has developed a novel air oxidation route for producing FDCA, significantly reducing production costs and enhancing competitiveness [11][12]. - Henan Haosen Biological Materials Co., Ltd. has pioneered a continuous production process for bio-based 1,5-pentanediol using non-food biomass, achieving large-scale and efficient green production [15]. Group 3: Award Categories and Timeline - The award features four main categories: Innovation Material Award, Innovation Application Award, Most Commercially Valuable Award, and Innovative Industry Solution Award, likened to the "Oscars" of the bio-based industry [19]. - The first round of applications is open until February 10, 2026, with subsequent voting and evaluation phases scheduled for March 2026, culminating in an award ceremony on May 21, 2026 [27].
利夫生物生物基聚酯获ISCC PLUS认证
Zhong Guo Hua Gong Bao· 2025-11-18 05:13
Core Insights - Hefei Lifetech Biotechnology Co., Ltd. has achieved ISCC PLUS certification for its core products FDCA and PEF, becoming the first globally to obtain this certification for FDCA/PEF products based on non-food raw materials [1] - Lifetech is the first company in the world to receive this certification for FDCA/PEF production, marking a significant milestone in the industry [1] - The certification process was supported by comprehensive technical documentation, process parameters, and carbon emission calculations provided by the Lifetech team, establishing a foundation for the standardization and global application of bio-based new materials [1]
宁波材料所技术,投资10亿的5万吨/年生物基新材料项目签约
DT新材料· 2025-10-17 16:07
Core Insights - The article highlights the establishment of a bio-based materials project by Yako Co., Ltd. in Huai'an Industrial Park, with an initial investment of 1 billion yuan and an expected annual sales revenue of 3 billion yuan from the first phase [1] - Yako Co., Ltd. is advancing the industrialization of FDCA and PEF based on a non-grain biomass technology route developed in collaboration with the Ningbo Institute of Materials Technology and Engineering [2] - The company has achieved a FDCA purity of 99.9% and is capable of supplying PEF at a ton-scale, focusing on applications in packaging [5] Group 1 - Yako Co., Ltd. was founded in 2003 and has evolved into a national high-tech enterprise with a diverse business scope, including life sciences, new materials, and green energy [4] - The FDCA's aromatic ring structure provides excellent thermal stability and rigidity, making it an ideal substitute for PTA, which has a significant global demand [4] - Yako's technology utilizes non-grain biomass such as corn cobs and plant straw, offering a more sustainable and cost-effective production method compared to mainstream routes [4] Group 2 - The company has completed trial samples with dozens of packaging enterprises and expects to enter mass production of its thousand-ton demonstration line by the second half of 2025 [5] - Yako Co., Ltd. has also achieved stable operation of a 50-ton/year demonstration line for PECF, which has better toughness compared to PEF [5] - The company is set to receive the New Leaf Award 2025 for its innovative materials at the 10th Bio-based Conference and Exhibition in May 2025 [5] Group 3 - The article mentions a forthcoming forum on high-value utilization of non-grain biomass, scheduled for November 2025, aimed at discussing strategic directions for biomass applications [6] - The forum will gather industry representatives and experts to explore topics such as biomass green pretreatment and sustainable aviation fuel [6] - The article emphasizes the need for addressing industrialization challenges in non-grain biomass utilization while highlighting emerging opportunities in the sector [5]
又一生物基材料企业,连续完成两轮融资
DT新材料· 2025-09-25 16:05
Core Insights - Xiangsheng Technology has recently completed two rounds of angel financing totaling several tens of millions, which will be used for the construction of an AI catalysis technology platform, product development, production line expansion, and smart factory construction [1] - The company aims to reduce production costs through its self-developed multiphase microflow matrix reaction platform, targeting high-barrier packaging scenarios [1] - Xiangsheng Technology has developed biocatalysts and nano-catalysts for the mass production of FDCA and PEF, providing microflow process development and mass production services to multiple industry clients [1] Financial Projections - By 2025, Xiangsheng Technology expects to have orders in hand and intentions reaching the million-level, with two strategic product lines contributing approximately 50% each to revenue [2] - The company anticipates a profit growth of 40%-50% over the next 3-4 years [2]
四大龙头加注!又一生物基企业获数亿元B2轮融资!
合成生物学与绿色生物制造· 2025-08-06 13:09
Core Viewpoint - Lifebio has recently completed a multi-billion B2 round financing led by the listed company Xin Fengming, with participation from GGV Capital and several existing shareholders [2][3]. Group 1: Company Overview - Lifebio is a leading global company in bio-based aromatic materials, having developed a unique "biomass-glucose-HMF-FDCA" process over more than a decade, which allows for the production of furan-based bio-materials without relying on food-sourced fructose [3][10]. - The company has established the world's first FDCA production line with a capacity of 1,000 tons and has initiated the construction of a 10,000-ton production line in Tongling, Anhui, in September 2024 [10][11]. Group 2: Investment and Partnerships - Xin Fengming, the lead investor in the recent financing round, is a major player in the polyester industry, with over 15% of global polyester filament capacity [4][7]. - GGV Capital, another significant investor, is a top-tier venture capital firm with over $9 billion in assets under management and a history of investing in over 500 companies, including Alibaba and Airbnb [7][8]. - Lifebio's previous investors include Lan Chuang Capital, which is associated with the listed company Zhongkong Technology, and Chengkai Fund, linked to Wankai New Materials, which has completed trial production of bio-based furan polyester [7][8]. Group 3: Industry Development - Lifebio has achieved the industry's first large-scale production of 100% bio-based polyester PEF filament through collaboration with leading companies [6][16]. - The company is focusing on non-food biomass sources such as corn cobs and straw to produce bio-based PEF, which can be applied in packaging materials, textiles, and electronics [13][19]. - Lifebio has signed a strategic cooperation agreement with Moutai to accelerate the application of bio-based materials in bottle caps and containers [19][20].
光大证券晨会速递-20250804
EBSCN· 2025-08-04 00:49
Group 1 - The report highlights a significant downward revision in the US non-farm employment data for June, with a total adjustment of 90,000 jobs, primarily affecting government, leisure, and construction sectors, indicating potential economic instability due to tariffs [2] - The Federal Reserve is expected to maintain a hawkish stance on inflation, with a possibility of 1-2 rate cuts in the second half of the year as trade negotiations progress [3] - The market is anticipated to enter a new upward phase in the second half of the year, with a focus on cyclical sectors and emerging industries [4][5] Group 2 - The FDCA industry is projected to grow significantly due to increasing demand for PEF as a superior alternative to PET, with recommended investments in companies like Tongkun Co., New Fengming, and Zhenhai Refining [13] - The "anti-involution" policy is expected to continue, benefiting sectors like photovoltaic materials, with a focus on price elasticity in the supply chain [14][16] - The coal industry is seeing improved price expectations due to recent policy measures, with recommendations for investments in major coal companies [18] Group 3 - Qingdao Bank reported a 7.5% year-on-year increase in revenue for the first half of 2025, with a net profit growth of 16%, indicating strong performance and asset quality [20] - China Petroleum & Chemical Corporation (Sinopec) anticipates a significant decline in net profit for the first half of 2025, but maintains a "buy" rating based on long-term competitive advantages [23] - Huaneng International's second-quarter net profit increased by 50% year-on-year, driven by lower fuel costs and expansion in renewable energy [24] Group 4 - Ningde Times reported a 33.73% year-on-year increase in net profit for the second quarter of 2025, with strong market positioning in lithium batteries and new product developments [25] - Tencent is expected to see strong growth in core gaming and advertising revenues, with an upward revision of profit forecasts for 2025-2027 [26] - Meta Platforms exceeded revenue expectations in Q2 2025, with plans for increased investment in AI infrastructure [27]
FDCA行业动态报告:FDCA发展潜力巨大,下游制成PEF替代空间广阔
EBSCN· 2025-08-01 10:22
Investment Rating - The report maintains a rating of "Overweight" for the FDCA industry [7] Core Insights - FDCA is a high-value bio-based compound with a wide range of applications, particularly in the production of PEF, which has significant market potential [1][3][5] - The global FDCA market is expected to grow at a compound annual growth rate (CAGR) of 8.9% from 2021 to 2028, potentially reaching USD 873.28 million by 2028 [3] - PEF, derived from FDCA, exhibits superior properties compared to PET, making it a promising alternative in various applications [4][5] Summary by Sections FDCA Overview - FDCA is a bio-based aromatic monomer derived from biomass such as starch and cellulose, recognized as a suitable substitute for terephthalic acid [1][14] - The synthesis routes for FDCA include chemical and biological methods, with the HMF route being the most promising for industrialization [1][26][27] Domestic and International Development - Internationally, several companies have achieved FDCA production since 2004, while domestic efforts began around 2010 and are rapidly advancing [2][45][56] - Notable international players include Avantium, Corbion Purac, and DuPont, which have made significant strides in FDCA and PEF research and production [45][46][48] Market Potential and Applications - The FDCA market is projected to exceed USD 1.13 billion by 2031, driven by increasing demand for bio-based products [3] - PEF's applications span food packaging, films, and fibers, with its oxygen and carbon dioxide barrier properties significantly outperforming PET [4][18][19] Investment Recommendations - The report suggests focusing on companies involved in FDCA production, such as Tongkun Co., New Fengming, and Zhenhai Refining & Chemical [5][58][60]
新凤鸣(603225):拟投资利夫生物,卡位生物基聚酯产业链
Huaan Securities· 2025-07-21 10:55
Investment Rating - The investment rating for the company is "Buy" (maintained) [2] Core Views - The company plans to invest 100 million RMB in Lif Biotechnology, acquiring a 7.0175% stake, which is a strategic move to position itself in the bio-based polyester industry chain [6][7] - Lif Biotechnology is a leading manufacturer of bio-based FDCA, a key material in the "green chemistry" sector, which has the potential to replace petrochemical-based PET in the long term [6][7] - The investment is expected to create synergies with the company's existing polyester business, despite short-term challenges such as the target company's losses and industrialization risks [7] Financial Summary - The company’s projected net profits for 2025, 2026, and 2027 are 1.344 billion, 1.845 billion, and 2.234 billion RMB respectively, with corresponding P/E ratios of 12.65, 9.21, and 7.61 [8] - Revenue is expected to grow from 67.091 billion RMB in 2024 to 81.610 billion RMB in 2027, with a compound annual growth rate (CAGR) of approximately 6.5% [11] - The gross margin is projected to improve from 5.6% in 2024 to 7.5% in 2027, indicating enhanced profitability [11]